Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acthar Gel in treatment-resistant idiopathic membranous nephropathy
NCT01386554Phase 4Completed
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- Aug 2011
- Primary completion
- Nov 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 5
01
Overview
A Phase 4 trial of repository corticotropin injection in idiopathic membranous nephropathy (IMN), sponsored by Mallinckrodt Pharmaceuticals. Started Aug 2011; status: completed.
02
Drugs
repository corticotropin injection
03
Conditions
idiopathic membranous nephropathy (IMN)
Beyond the preview
Go deeper on NCT01386554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01386554.